This live session has been archived
Wed,
May 12, 2021 |
7:00PM -
8:30PM EDT
Humber River Health Presents
CKD and Diabetes – The Role of SGLT2 Inhibitors in Modifying the Risk of Progressive Kidney Disease
Jordan Weinstein, MD, FRCPC
Topics: CKD, Diabetes
This live session has been archived
Session evaluations are closed but you may download a copy of your certificate of attendance.
Moderated by: Dr. Arthur Kushner
Details
Objectives
- Assess the impact of DKD on cardio-renal outcomes in patients with T2D.
- Explain the role of SGLT2i in treatment of DKD.
- Discuss clinical considerations for SGLT2i in the management of DKD and identify opportunities for optimizing care.
Faculty
Jordan Weinstein MD, FRCPC
Nephrologist, St. Michael’s Hospital
Associate Professor of Medicine, University of Toronto
Associate Professor of Medicine, University of Toronto
Dr. Weinstein is a nephrologist at St. Michael's Hospital in Toronto and Associate Professor of Medicine at the University of Toronto. He served on the educational committee of the International Society of Nephrology. Dr. Weinstein's clinical interests are in diabetic hypertension and chronic kidney disease, kidney stones and management of end-stage renal failure. He has led several hundred continuing medical education events at a regional, national and international level.